RESI, virtual, June 2021, 31 pages Presentation Presentation
Author: Venture Valuation
Workshop: Company Valuation for Fundraising – Trends & Tools
Venture Valuation held a workshop at the May 2021 edition of Biotechgate Digital Partnering, covering topics such as advice on speaking with investors and valuing a life science company with limited revenue – presented by Dr. Patrik Frei and Dr. Gergely Iványi on May 3rd, 2021. The full workshop can be viewed here, while slides … Continue reading Workshop: Company Valuation for Fundraising – Trends & Tools
Forty51 Ventures, newly established venture capital firm
April 2021: Started in Basel by three experienced Partners, Forty51 Ventures targets seed and early-stage investments in underfunded Biotech clusters in Switzerland, Germany, Eastern France, Northern Italy, and Austria. Venture Valuation (VV) interviewed Sascha Oliver Bucher, Co-Founder and Partner. Read the Interview Would you like to be notified about new interviews, reports and other valuable … Continue reading Forty51 Ventures, newly established venture capital firm
RESI Conference March 2021 – Product Valuation for Deal-Making
RESI, virtual, March 2021, 23 pages Presentation
RESI Conference March 2021 – Company Valuation for Fundraising: Trends and Tools
RESI, virtual, March 2021, 31 pages Presentation
Enterprise Lithuania becomes a partner of Venture Valuation/Biotechgate
Media release Enterprise Lithuania becomes a partner of Venture Valuation/Biotechgate Zurich / Vilnius, Jan 2021 Venture Valuation/Biotechgate announce a cooperation with Enterprise Lithuania, trade promotion governmental agency. As per the agreement of the two parties, the Lithuanian Biotech Database has been set-up, a regional portal integrated with Biotechgate Business Development Database. Access to the portal … Continue reading Enterprise Lithuania becomes a partner of Venture Valuation/Biotechgate
Trends and facts on licensing deals
Workshop about trends and facts on licensing deals. Presented at Biotechgate Digital Partnering November 2020 by Venture Valuation’s Dr. Patrik Frei and Elias Neuendorf. Presentation
Determine Your Company Valuation With a Little More Confidence
Norway Healthtech, virtual, November 2020, 27 pages Presentation
Valuation Through A Health Lense & What Professional Investors Look For
Norway Healthtech, virtual, October 2020, 29 pages Presentation
Interviews with leading Life Sciences companies: FRONTEO Inc.
September 2020: Expert in big data analysis primarily in the legal tech business using its NLP AI technology, FRONTEO is applying its knowhow in the fields of life sciences and health care. Venture Valuation (VV) interviewed TOYOSHIBA Hiroyoshi PhD, CTO Life Science AI Business Division, and YAMAMOTO Mari, Member of the Board of Directors. Read … Continue reading Interviews with leading Life Sciences companies: FRONTEO Inc.